Brisbane based AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care ...
See-Mode Technologies, a medtech startup headquartered in Australia, and with operations in Singapore, has announced tha...
Australia has inked an agreement with British pharmaceutical giant AstraZeneca to supply Australians with the ...
US based Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of d...
Public and private service providers are invited to apply for grants totalling $45.5 million, to develop regional radiat...
Australians with certain cancers and infants with severe epilepsy will benefit from new medications being listed or exte...
Australia is progressing with its new and improved Q Fever vaccine at pre-clinical trials following a $1.87 million inje...
The Australian Government is providing 10 additional Medicare-subsidised psychological therapy sessions for Australians ...
Australia based biopharmaceutical contract manufacturing organisation Luina Bio has recently partnered with XING Technol...
Australia's The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, D...
US based Colorcon, a world leader in the development and supply of film coating systems and excipients, has announced th...
A record number of Australian GPs and patients now have greater access to Medical Cannabis after a landmark deal was sig...
Vaccine manufacturers seeking listing on the National Immunisation Program (NIP) Schedule must ask for advice from ...
UK based Biocomposites, an international medical devices company that engineers, manufactures and markets world leading ...
Australia based Atomo Diagnostics has announced that it has signed a binding agreement with US-based diagnostics special...
Melbourne-based Affinity Biosciences Pty Ltd (Affinity) has lodged a pre-publication submission to the scientific journa...
The Australian government’s landmark Medical Research Future Fund (MRFF) has reached maturity at $20 billion. This...
The Australian government is backing cutting-edge research into two of the most prominent health conditions that affect ...
